Nabi Biopharmaceuticals' Other Investors

Nabi Biopharmaceuticals raised a round of funding on , . Investors include Merlin Nexus.

has a broad product portfolio that modulates the immune system. Their research focuses on developing and commercializing novel vaccines and antibody-based therapies that prevent and treat infectious, …

Articles about Nabi Biopharmaceuticals' Other Investors: